CA2165792A1 - Derives du tetrazole - Google Patents

Derives du tetrazole

Info

Publication number
CA2165792A1
CA2165792A1 CA002165792A CA2165792A CA2165792A1 CA 2165792 A1 CA2165792 A1 CA 2165792A1 CA 002165792 A CA002165792 A CA 002165792A CA 2165792 A CA2165792 A CA 2165792A CA 2165792 A1 CA2165792 A1 CA 2165792A1
Authority
CA
Canada
Prior art keywords
atom
compound
tetrazol
propyl
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002165792A
Other languages
English (en)
Inventor
Masatoshi Hayashi
Masaya Kato
Yusuke Sakai
Kazuhiko Mitsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Steel Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2165792A1 publication Critical patent/CA2165792A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Dérivé tétrazolique répondant à la formule générale (1), dans laquelle A représente -CH=CH-, -CH2-CH2-, -CH2O-, un atome d'oxygène ou un atome de soufre, ou, au cas où A ne relierait pas entre eux les cycles aromatiques voisins, A représente deux atomes d'hydrogène dont chacun est lié au cycle aromatique voisin; V représente -CH=CH-, ou un atome de soufre; X et Y, indépendamment l'un de l'autre, représentent un groupe alcoxy, un atome d'halogène ou un atome d'hydrogène; (a) W représente une liaison, Z représente un atome de carbone ou méthine, et B forme une liaison conjointement avec Z ou représente un groupe hydroxyle, ou (b) W, Z et B représentent respectivement une liaison, un atome d'azote et un atome d'hydrogène, ou (c) W, Z et B représentent respectivement un atome d'oxygène, méthine et un atome d'hydrogène; p est 2 ou 3; et n est un nombre entier compris entre 1 et 6; ou son sel pharmacologiquement acceptable; et agent antihistaminique, agent antiallergique ou agent de traitement de l'asthme le contenant.
CA002165792A 1993-06-29 1994-06-23 Derives du tetrazole Abandoned CA2165792A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP158745/1993 1993-06-29
JP15874593 1993-06-29
JP158741/1993 1993-06-29
JP15874193 1993-06-29
JP138756/1994 1994-06-21
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体

Publications (1)

Publication Number Publication Date
CA2165792A1 true CA2165792A1 (fr) 1995-01-12

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002165792A Abandoned CA2165792A1 (fr) 1993-06-29 1994-06-23 Derives du tetrazole

Country Status (8)

Country Link
EP (1) EP0706522A1 (fr)
JP (1) JP3338913B2 (fr)
KR (1) KR960703405A (fr)
AU (1) AU673754B2 (fr)
CA (1) CA2165792A1 (fr)
IL (1) IL110144A0 (fr)
TW (1) TW281677B (fr)
WO (1) WO1995001350A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
CA2261633A1 (fr) * 1996-07-29 1998-02-05 Banyu Pharmaceutical Co., Ltd. Antagonistes de recepteurs de chemokines
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
WO2003032912A2 (fr) 2001-10-16 2003-04-24 Hypnion, Inc. Traitement de troubles du systeme nerveux central (snc) a l'aide de modulateurs de cible snc
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
BR0316747A (pt) * 2002-12-18 2005-10-18 Fmc Corp Piperidinas n-(arilmetil substituìdas)-4-(metil dissubstituìdas) e piperazinas
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7524864B2 (en) 2004-04-23 2009-04-28 Hypnion, Inc. Methods of treating sleep disorders
WO2007018460A1 (fr) * 2005-08-08 2007-02-15 Astrazeneca Ab Agents thérapeutiques
PT2319840E (pt) * 2008-08-01 2016-02-10 Nippon Zoki Pharmaceutical Co Derivado de aminopropilideno
EP3645257A1 (fr) * 2017-06-30 2020-05-06 Nikon Corporation Procédé de production d'un dispositif optique et système correspondant
WO2019203296A1 (fr) 2018-04-19 2019-10-24 国立大学法人東京農工大学 Agents préventifs et thérapeutiques de la sarcopénie
CN113880808A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
JPH0770112A (ja) 1995-03-14
JP3338913B2 (ja) 2002-10-28
TW281677B (fr) 1996-07-21
WO1995001350A1 (fr) 1995-01-12
KR960703405A (ko) 1996-08-17
EP0706522A1 (fr) 1996-04-17
IL110144A0 (en) 1994-10-07
AU6983094A (en) 1995-01-24
AU673754B2 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
EP0100200B1 (fr) Amino-4 diméthoxy-6,7 quinoléines substituées en position 2
CA2165792A1 (fr) Derives du tetrazole
DE602005002470T2 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
US5877187A (en) Benzimidazole derivatives with antihistaminic activity
DE60309913T2 (de) BICYCLISCHE BENZAMIDVERBINDUNGEN ALS FüR DIE BEHANDLUNG NEUROLOGISCHER KRANKHEITEN GEEIGNETE HISTAMIN-H3-REZEPTORLIGANDEN
US7671080B2 (en) 1-benzylindole-2-carboxamide derivatives
US4680296A (en) Piperidine derivatives and pharmaceutical compositions containing them
CA2144669A1 (fr) Derives du biphenyle
WO1997013766A1 (fr) Derives heteroaromatiques substitues
DE3507983A1 (de) 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazin-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE2939292A1 (de) N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
CA2045453C (fr) Compose heterocyclique condense et composition psychopharmaceutique le contenant
DD291323A5 (de) Verfahren zur herstellung von piperidinen
FR2465732A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
US5432179A (en) Piperazine derivatives and pharmaceuticals containing the same
IE921340A1 (en) Heterocyclic antiserotonin derivatives, their preparation¹and pharmaceutical compositions containing them
EP1210335B1 (fr) Derives de benzimidazol substitues aminocabonyle, leur procede de preparation et leur utilisation comme produit pharmaceutique
US5095022A (en) Piperidine derivatives and pharmaceutical compositions comprising the same
US5013736A (en) Azaazulene compounds which are useful as antiallergic and antiinflammatory agents
JPS58206588A (ja) 抗潰瘍性２−グアニジノ−４−（２−置換−アミノ−４−イミダゾリル）チアゾ−ル類およびそれらの製造方法
DE69827233T2 (de) Diaminderivate und diese enthaltende arzneimittel
AU600378B2 (en) Piperidine derivatives, their preparation and their application in therapy
EP0579059B1 (fr) Dérivés de pyridazinone et procédé de préparation
US4766215A (en) Histamine H1 -receptor antagonists
DE69732551T2 (de) Flavon Derivative und deren enthaltende Arzneimittel

Legal Events

Date Code Title Description
FZDE Discontinued